Connor, Clark & Lunn Investment Management (CC&L)
ZYME icon

Connor, Clark & Lunn Investment Management (CC&L)’s Zymeworks ZYME Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$949K Buy
+37,919
New +$897K ﹤0.01% 1171
2025
Q4 		– Sell
-96,800
Closed -$1.65M – 1817
2025
Q3 		$1.65M Buy
+96,800
New +$1.39M 0.01% 913
2024
Q2 		– Sell
-80,701
Closed -$849K – 1736
2024
Q1 		$849K Sell
80,701
-1,773
-2% -$19.7K ﹤0.01% 927
2023
Q4 		$857K Buy
82,474
+64,552
+360% +$514K ﹤0.01% 902
2023
Q3 		$114K Sell
17,922
-38,931
-68% -$288K ﹤0.01% 1286
2023
Q2 		$491K Buy
56,853
+15,549
+38% +$139K ﹤0.01% 988
2023
Q1 		$373K Buy
+41,304
New +$360K ﹤0.01% 964
2022
Q4 		– Sell
-24,583
Closed -$151K – 1456
2022
Q3 		$151K Buy
24,583
+8,296
+51% +$50K ﹤0.01% 1020
2022
Q2 		$86K Buy
+16,287
New +$98.5K ﹤0.01% 990

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s ZYME Position: Q1 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) opened a new position in Zymeworks (ZYME) in Q1 2026: 37,919 shares worth $949K. The stake represents ﹤0.01% of the portfolio and ranks #1171 among its holdings. This is a return to the name: Connor, Clark & Lunn Investment Management (CC&L) previously reported a position in ZYME as recently as Q3 2025.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ZYME in Q2 2022 and has held it in 9 quarters since. The position peaked at $1.65M in Q3 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) held 37,919 shares of Zymeworks worth $949K as of Q1 2026.
  • Zymeworks was a new Connor, Clark & Lunn Investment Management (CC&L) position in Q1 2026.
  • Zymeworks made up ﹤0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q1 2026, its #1171 holding.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Zymeworks in Q2 2022 and has held it in 9 quarters since.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Zymeworks position peaked at $1.65M in Q3 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2026, filed 11 May 2026.